| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 19.07 | -0.08 (-0.42%) | 12.92 - 19.68 | 3.5 thousand (Below Avg) |
Market data as of 4:00PM 05/24/13. Quotes are delayed by at least 15 min.
| Open | 18.87 |
|---|---|
| Previous Close | 19.15 |
| Day's Range | 18.87 - 19.22 |
| Market Cap | 185.2M |
| Avg Volume (10 Day) | 15.5K |
| Price/Earnings (Trailing 12 Mo.) | 11.2x |
| Earnings Per Share (Trailing 12 Mo.) | 1.7 |
| Dividend Yield | No Dividend |


These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Performed well consistently? | Fail |
|---|---|
| Avoids excess debt? | Fail |
| Converting sales to profits? | Fail |
| Shareholder's money handled rationally? | Neutral |
| Increased shareholder value? | Neutral |
| Consistently increased owner earnings? | Fail |
| Sells at 25% discount to intrinsic value? | Fail |


These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Pays a cash dividend? | Fail |
|---|---|
| Room to increase dividends? | Fail |
| Increased earnings over time? | Fail |
| Borrows within reasonable limits? | Pass |
| Stock is undervalued? | Pass |
| Have investors caught on? | Pass |
| Has support of institutional investors? | Pass |
| Has sufficient liquidity? | Pass |
Nutraceutical Reports Fiscal 2013 Q2 Results
PR Newswire - Thursday 04/25/2013 7:00 AM ET
| NUTR | Industry Range | |
|---|---|---|
| Revenue Growth (1yr) | 6.41% | |
| Net Income Growth (1yr) | -15.51% | |
| Total Debt/Equity | 0.27 | |
| LT Debt/Equity | 0.27 | |
| Earnings Yield | 8.93% | |
| Price/Sales | 0.90 |
| Company | Last | Change |
|---|---|---|
| Blyth Inc | 14.27 | -0.83% |
| United-Guardian Inc | 26.51 | +2.81% |
| Female Health Co | 8.94 | +0.90% |
| Summer Infant Inc | 3.40 | -3.68% |
| Mannatech Inc | 9.89 | +4.55% |
Data is delayed by at least 15 min.